Search Results

Your search for Julie R. Gralow, MD, FASCO matches 102 pages

Showing 101 - 102

By ASCO / April 25, 2018

ASCO Honors Leaders in Cancer Care With 2018 Special Awards

ASCO and ASCO’s Conquer Cancer Foundation are proud to recognize the winners of ASCO’s Special Awards and Conquer Cancer’s Women Who Conquer Cancer Mentorship Awards. The recipients of these awards include researchers, patient advocates, and global oncology leaders who have worked to transform...

breast cancer

By Julie R. Gralow, MD, FASCO / February 10, 2018

Bone-Modifying Agents in Metastatic Breast Cancer: Time to De-escalate Dosing Intervals

AS REVIEWED in this issue of The ASCO Post, ASCO and Cancer Care Ontario (CCO) have issued an updated guideline on the role of bone-modifying agents in metastatic breast cancer.1 The updated guideline supports a change in clinical practice for our patients with breast cancer and bone metastasis....

Sep

Today In Oncology

Search Results

Your search for Julie R. Gralow, MD, FASCO matches 102 pages

ASCO Honors Leaders in Cancer Care With 2018 Special Awards

Bone-Modifying Agents in Metastatic Breast Cancer: Time to De-escalate Dosing Intervals

FDA Approves Belzutifan in Combination With Lenvatinib for Advanced ccRCC

FDA Advisory Committee Votes In Favor of Approval of Multi-Cancer Early Detection Test

New AI Model Outperforms Oncotype DX for Predicting Recurrence Risk in Breast Cancer

CAP Updates Cancer Protocols for Breast Cancer Biomarker Reporting and GIST Molecular Testing

Robert Kyle Myeloma Expert Dies at 98